Cancer · 1999 · 64 citations · 35 references
MedicineClinical SciencesOncologyChemotherapyMedical OncologyMetastasisCytokine-based TherapyMelanocytic TumorsMelanoma PharmacotherapyMetastatic Cancer ManagementMetastatic Disease TreatmentTumor Lysis SyndromeCancer Cell LysisChemotherapy-associated Tumor Lysis SyndromeMalignant Melanocytic TumorsMetastatic Melanoma TreatmentRefractory Solid Tumors
BACKGROUND: Treatment of solid tumors rarely has been associated with tumor lysis syndrome. However, to the authors' knowledge the clinical scenario has not been reported previously in melanoma patients. METHODS: A patient with bulky metastatic melanoma was treated with concurrent biochemotherapy using interleukin-2, interferon-alpha, and a combination of cisplatin, vinblastine, and dacarbazine. RESULTS: Within 24 hours of the initiation of treatment, brisk tumor lysis occurred and led to a fatal outcome. CONCLUSIONS: Improvements in the treatment of solid tumors may increase the incidence of tumor lysis syndrome for tumors once believed to be marginally responsive. Oncologists should remain cognizant of this problem as more active regimens become available.
35
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1991 · 8.5K citations
Medicine, Oncology, Oncology Nursing +10
Angela Joyce · Paediatric Care · 1989 · 3.4K citations
Medicine, Hematology, Pediatrics +11
Rosemary Ford, Seth Eisenberg · Nursing Clinics of North America · 1990 · 2.7K citations
Cancer: Principles and Practice of Oncology
Walter G. Gunn · JAMA · 1994 · 1.8K citations
Medicine, Oncology, Oncology Nursing +10
Lawrence F. Cohen, James E. Balow, Ian Magrath et al. · The American Journal of Medicine · 1980 · 433 citations